Dna X, INC. (SONM) — SEC Filings

Q: What are the key financial highlights for Dna X, INC.?

Key financial highlights for Dna X, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Dna X, INC.?

Key executives at Dna X, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Dna X, INC. stock?

Risk factors for Dna X, INC. (SONM) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Dna X, INC.?

Forward-looking statements and predictions from Dna X, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Dna X, INC.. Recent 10-K filing on Apr 15, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Dna X, INC. on SEC EDGAR

Overview

Dna X, INC. (SONM) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Dec 19, 2025: Sonim Technologies, Inc. is filing a supplemental proxy statement for a special meeting of stockholders scheduled for December 30, 2025. This filing provides additional materials related to the proxy statement, indicating that the company is seeking shareholder approval for matters to be discussed a

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 1 bullish, 5 bearish, 42 neutral, 2 mixed. The dominant filing sentiment for Dna X, INC. is neutral.

Filing Type Overview

Dna X, INC. (SONM) has filed 2 10-K, 25 8-K, 16 DEFA14A, 2 10-Q, 1 S-1/A, 1 S-1, 1 DEF 14A, 1 10-K/A, 1 SC 13D with the SEC between Sep 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

10-K Filing — 10-K · Apr 15, 2026
8-K Filing — 8-K · Dec 31, 2025
DEFA14A Filing — DEFA14A · Dec 29, 2025
Sonim Technologies Calls Special Stockholder Meeting — DEFA14A · Dec 19, 2025 Risk: low
Sonim Technologies, Inc. is filing a supplemental proxy statement for a special meeting of stockholders scheduled for December 30, 2025. This filing provides ad
8-K Filing — 8-K · Dec 18, 2025
Sonim Technologies Reports Officer/Director Changes — 8-K · Dec 5, 2025 Risk: medium
Sonim Technologies, Inc. filed an 8-K on December 5, 2025, reporting events as of December 1, 2025. The filing pertains to the departure of directors or certain
Sonim Technologies Files 8-K on Material Agreement — 8-K · Nov 26, 2025 Risk: medium
Sonim Technologies, Inc. filed an 8-K on November 26, 2025, reporting on a material definitive agreement entered into on November 24, 2025. The filing also incl
DEFA14A Filing — DEFA14A · Nov 25, 2025
Sonim Technologies Files 8-K for Other Events — 8-K · Nov 13, 2025 Risk: low
Sonim Technologies, Inc. filed an 8-K on November 13, 2025, reporting an event that occurred on November 12, 2025. The filing indicates 'Other Events' as the it
Sonim's Q3 Loss Widens Amid Revenue Growth, Strategic Shift — 10-Q · Oct 31, 2025 Risk: high
Sonim Technologies Inc. reported a net loss of $4.753 million for the three months ended September 30, 2025, an increase from a net loss of $2.512 million in th
Sonim Technologies Files 8-K on Security Holder Rights — 8-K · Oct 24, 2025 Risk: medium
Sonim Technologies, Inc. filed an 8-K on October 24, 2025, reporting material modifications to the rights of security holders and amendments to its articles of
Sonim Technologies Faces Delisting Concerns, Board Changes — 8-K · Oct 20, 2025 Risk: high
Sonim Technologies, Inc. filed an 8-K on October 20, 2025, reporting events as of October 16, 2025. The filing indicates a potential notice of delisting or fail
Sonim Seeks $500M Equity Infusion Amid Nasdaq Delisting Threat — S-1/A · Oct 9, 2025 Risk: high
Sonim Technologies, Inc. (SONM) filed an S-1/A on October 9, 2025, detailing a committed equity facility (the "Facility") with Chardan Capital Markets LLC. Unde
Sonim Files S-1 for $500M Equity Facility Amid Nasdaq Delisting Threat — S-1 · Sep 29, 2025 Risk: high
Sonim Technologies, Inc. (SONM) filed an S-1 registration statement on September 29, 2025, for the potential resale of up to 350,000,000 shares of common stock
Sonim Seeks Reverse Split, Massive Share Increase to Avoid Delisting — DEF 14A · Sep 19, 2025 Risk: high
Sonim Technologies, Inc. (SONM) is holding a Special Meeting on October 16, 2025, to address critical corporate actions. The company proposes a reverse stock sp
Sonim Technologies Faces Delisting Concerns — 8-K · Aug 27, 2025 Risk: high
Sonim Technologies, Inc. filed an 8-K on August 27, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the e
Sonim Technologies Faces Delisting Notice — 8-K · Aug 14, 2025 Risk: high
Sonim Technologies, Inc. filed an 8-K on August 14, 2025, reporting a notice of delisting or failure to satisfy continued listing requirements as of August 13,
Sonim Technologies Reports Material Agreement, Officer Changes — 8-K · Aug 12, 2025 Risk: medium
Sonim Technologies, Inc. announced on August 7, 2025, the entry into a material definitive agreement and the creation of a direct financial obligation. The comp
Sonim Technologies Files DEFA14A for Annual Meeting — DEFA14A · Aug 8, 2025 Risk: low
Sonim Technologies, Inc. filed a DEFA14A on August 8, 2025, related to its annual meeting. The filing details executive compensation, director elections, and ot
Sonim Technologies Reports Board and Executive Changes — 8-K · Jul 23, 2025 Risk: medium
Sonim Technologies, Inc. announced on July 17, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure
Sonim Technologies Stockholders Elect All Nominees — DEFA14A · Jul 22, 2025 Risk: low
Sonim Technologies, Inc. (NASDAQ: SONM) held its 2025 Annual Meeting of Stockholders on July 22, 2025, where all five nominated directors were elected. The comp
Sonim Technologies Acquired by Social Mobile for $20M — DEFA14A · Jul 18, 2025 Risk: medium
Sonim Technologies Inc. is filing a DEFA14A proxy statement regarding its acquisition by Social Mobile. The transaction is valued at $20 million and is expected
Sonim Technologies Files 8-K for Material Agreement — 8-K · Jul 17, 2025 Risk: medium
Sonim Technologies, Inc. entered into a material definitive agreement on July 11, 2025, related to a direct financial obligation. The company, incorporated in D
Sonim Recommends Voting For Management Nominees — DEFA14A · Jul 14, 2025 Risk: medium
Sonim Technologies Inc. has filed a DEFA14A proxy statement, recommending shareholders vote for management nominees. Institutional Shareholder Services (ISS) su
Sonim Technologies Recommends Voting FOR Company Nominees — DEFA14A · Jul 11, 2025 Risk: medium
Sonim Technologies Inc. (SONM) has filed a DEFA14A proxy statement, recommending stockholders vote "FOR" the company's nominees. Institutional Shareholder Servi
Sonim Technologies Proxy Filing & Employee Share Reminders — DEFA14A · Jul 9, 2025 Risk: low
Sonim Technologies Inc. filed a DEFA14A on July 9, 2025, related to proxy materials. The filing includes emails sent to employees on July 8, 2025, reminding the
Sonim Technologies Proxy Filing Addresses Orbic Financing Concerns — DEFA14A · Jul 7, 2025 Risk: medium
Sonim Technologies, Inc. filed a DEFA14A on July 7, 2025, related to proxy materials. The filing includes an email sent to Institutional Shareholder Services (I
Sonim Technologies Files 8-K — 8-K · Jul 2, 2025 Risk: low
Sonim Technologies, Inc. filed an 8-K on July 2, 2025, reporting events as of July 1, 2025. The filing indicates "Other Events" and "Financial Statements and Ex
Sonim Technologies Files Proxy Materials — DEFA14A · Jun 27, 2025 Risk: low
Sonim Technologies Inc. filed a Definitive Additional Materials (DEFA14A) on June 27, 2025. This filing indicates that no fee was required for this filing, as i
Sonim Technologies Files Proxy Materials, CFO Emails Employees — DEFA14A · Jun 26, 2025 Risk: low
Sonim Technologies, Inc. filed a DEFA14A on June 26, 2025, which included an email sent by CFO Clay Crolius to employees. The email, dated June 26, 2025, addres
Sonim Technologies Files 8-K — 8-K · Jun 25, 2025 Risk: low
Sonim Technologies, Inc. filed an 8-K on June 25, 2025, reporting on other events and financial statements. The filing does not contain specific financial figur
Sonim Technologies Reviews Strategic Alternatives — DEFA14A · Jun 20, 2025 Risk: medium
Sonim Technologies Inc. is filing a Definitive Additional Materials proxy statement regarding its annual meeting on July 18th. The Board of Directors has initia
Sonim Technologies Updates Strategic Alternatives, Seeks Director Support — DEFA14A · Jun 18, 2025 Risk: medium
Sonim Technologies Inc. filed a DEFA14A on June 18, 2025, providing an update on its strategic alternatives initiatives. The company is urging stockholders to s
Sonim Technologies Receives Unsolicited Interest — DEFA14A · Jun 16, 2025 Risk: medium
Sonim Technologies Inc. confirmed on June 16, 2025, that its Special Committee of the Board of Directors received a non-binding, unsolicited indication of inter
Sonim Technologies Changes Auditors to Armanino LLP — 8-K · Jun 5, 2025 Risk: low
Sonim Technologies, Inc. announced on June 3, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public
Sonim Technologies to Sell Assets to Social Mobile — DEFA14A · Jun 2, 2025 Risk: medium
Sonim Technologies, Inc. announced on June 2, 2025, that it has signed a Letter of Intent to sell substantially all of its assets to Social Mobile. This strateg
Sonim Technologies Files 8-K on Material Agreement — 8-K · May 16, 2025 Risk: medium
Sonim Technologies, Inc. filed an 8-K on May 16, 2025, reporting a material definitive agreement entered into on May 12, 2025. The filing also covers unregister
Sonim Technologies Files 8-K on Financials — 8-K · May 12, 2025 Risk: low
Sonim Technologies, Inc. filed an 8-K on May 12, 2025, reporting on its results of operations and financial condition, and including financial statements and ex
Sonim Technologies Files 2024 Annual Report Amendment — 10-K/A · Apr 29, 2025 Risk: medium
Sonim Technologies, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This filing, dated April 29, 2025, provid
Sonim Technologies Reports Key Corporate Changes — 8-K · Apr 21, 2025 Risk: medium
On April 17, 2025, Sonim Technologies, Inc. filed an 8-K report detailing several significant corporate events. These include entering into a material definitiv
Sonim Technologies Announces Director and Officer Changes — 8-K · Apr 16, 2025 Risk: medium
Sonim Technologies, Inc. announced on April 15, 2025, changes related to its board of directors and executive compensation. The filing details the departure of
Sonim Technologies Appoints New CEO and Board Members — 8-K · Apr 3, 2025 Risk: medium
Sonim Technologies, Inc. announced on April 2, 2025, several key executive and board changes. The company appointed Robert J. Schimek as Chief Executive Officer
Sonim Technologies Files 2024 10-K — 10-K · Mar 31, 2025 Risk: medium
Sonim Technologies Inc. filed its 2024 10-K report on March 31, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The comp
Sonim Technologies Files 8-K on Material Agreement — 8-K · Feb 21, 2025 Risk: medium
On February 21, 2025, Sonim Technologies, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers the creation of a direct fi
Sonim Technologies Announces Executive and Director Changes — 8-K · Feb 11, 2025 Risk: medium
Sonim Technologies, Inc. announced on February 6, 2025, changes in its executive and director roles. The company filed an 8-K report detailing the departure of
Sonim Technologies Files 8-K — 8-K · Jan 23, 2025 Risk: low
Sonim Technologies, Inc. filed an 8-K on January 23, 2025, reporting an event that occurred on January 22, 2025. The filing is categorized under 'Other Events'
Sonim Technologies Files 8-K on Financials — 8-K · Jan 16, 2025 Risk: low
Sonim Technologies, Inc. filed an 8-K on January 16, 2025, reporting on its results of operations and financial condition as of January 15, 2025. The filing inc
Sonim Technologies Files Q3 2024 10-Q — 10-Q · Nov 13, 2024 Risk: medium
Sonim Technologies Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position, including
Peter Liu Files SC 13D for Sonim Technologies — SC 13D · Oct 18, 2024 Risk: medium
Peter Liu, through an entity, has filed a Schedule 13D for Sonim Technologies, Inc. (SONM) on October 18, 2024. The filing indicates a change in beneficial owne
Sonim Technologies Enters Material Definitive Agreement — 8-K · Sep 27, 2024 Risk: medium
Sonim Technologies, Inc. entered into a material definitive agreement on September 23, 2024. This agreement creates a direct financial obligation for the regist

Risk Profile

Risk Assessment: Of SONM's 45 recent filings, 7 were flagged as high-risk, 25 as medium-risk, and 13 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Dna X, INC.'s most recent 10-Q filing (Oct 31, 2025):

Revenue: $16.214M
Net Income: -$4.753M
EPS: N/A
Debt-to-Equity: N/A
Cash Position: $2.137M
Operating Margin: N/A
Total Assets: N/A
Total Debt: N/A

Key Executives

Peter Liu
William N. Haddad, Esq.
Kirill Y. Nikonov, Esq.
Arif Soto, Esq.
Clay Crolius
Robert J. Schimek
Michael P. Mulica
David J. Glickman

Industry Context

Sonim operates in the rugged mobile device market, a niche segment catering to enterprise and industrial users requiring durable hardware. This sector is characterized by intense competition from established players and specialized manufacturers. Key industry trends include the integration of advanced IoT capabilities, enhanced security features, and longer product lifecycles to meet the demands of harsh working environments.

Top Tags

proxy-statement (13) · material-agreement (7) · corporate-governance (7) · filing (5) · 8-k (4) · Reverse Stock Split (4) · financial-obligation (4) · financials (3) · filing-update (3) · delisting (3)

Key Numbers

Total net revenues (Q3 2025): $16.214M — Increased from $15.022M in Q3 2024
Net loss (Q3 2025): $4.753M — Widened from $2.512M in Q3 2024
Cash and cash equivalents (Sept 30, 2025): $2.137M — Decreased from $5.343M at Dec 31, 2024
Net cash used in operating activities (9 months 2025): $21.522M — Increased significantly from $3.977M in 9 months 2024
Reverse stock split ratio: 1-for-18 — Effective October 27, 2025, to maintain Nasdaq listing
Gross profit (Q3 2025): $1.816M — Decreased from $4.232M in Q3 2024
Cost of revenues (Q3 2025): $14.398M — Increased from $10.790M in Q3 2024
Total stockholders' deficit (Sept 30, 2025): $701K — Improved from $5.700M deficit at Dec 31, 2024, but still negative
Shares outstanding (Oct 28, 2025): 1,028,693 — Post-reverse stock split adjustment
Total net revenues (9 months 2025): $44.125M — Increased from $43.314M in 9 months 2024
Maximum aggregate gross proceeds: $500.0 million — Potential proceeds from sales to Chardan under the Purchase Agreement
Maximum shares of common stock: 350,000,000 — Shares potentially issuable to Chardan Capital Markets LLC
Last quoted sale price per share: $0.7262 — SONM's closing price on Nasdaq on October 8, 2025, below the $1.00 minimum
Nasdaq minimum bid price requirement: $1.00 — Threshold SONM must meet to avoid delisting
Nasdaq minimum stockholders' equity requirement: $2,500,000 — Threshold SONM must meet to avoid delisting

Related Companies

SON

Frequently Asked Questions

What are the latest SEC filings for Dna X, INC. (SONM)?

Dna X, INC. has 50 recent SEC filings from Sep 2024 to Apr 2026, including 25 8-K, 16 DEFA14A, 2 10-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of SONM filings?

Across 50 filings, the sentiment breakdown is: 1 bullish, 5 bearish, 42 neutral, 2 mixed. The dominant sentiment is neutral.

Where can I find Dna X, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Dna X, INC. (SONM) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Dna X, INC.?

Key financial highlights from Dna X, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for SONM?

The investment thesis for SONM includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Dna X, INC.?

Key executives identified across Dna X, INC.'s filings include Peter Liu, William N. Haddad, Esq., Kirill Y. Nikonov, Esq., Arif Soto, Esq., Clay Crolius and 3 others.

What are the main risk factors for Dna X, INC. stock?

Of SONM's 45 assessed filings, 7 were flagged high-risk, 25 medium-risk, and 13 low-risk.

What are recent predictions and forward guidance from Dna X, INC.?

Forward guidance and predictions for Dna X, INC. are extracted from SEC filings as they are enriched.